<DOC>
	<DOCNO>NCT00505934</DOCNO>
	<brief_summary>Keppra injection approve US adjunctive therapy treatment partial onset seizure adult epilepsy . The objective current study ass safety , tolerability , pharmacokinetics , formulation child age 1 month 4 year .</brief_summary>
	<brief_title>Open-label Study Levetiracetam Intravenous Infusion Children ( 1 Month-4 Years Old ) With Epilepsy</brief_title>
	<detailed_description>The primary objective study evaluate safety tolerability levetiracetam intravenous 15-minute infusion administer every 12 hour , either adjunctive treatment monotherapy child ( 1 month 4 year old ) epilepsy ( except status epilepticus ) , either switch equivalent levetiracetam oral dose administration new antiepileptic treatment . The evaluation period consider one complete set 4 pharmacokinetic ( PK ) sample maximum 4 day ; For child already take levetiracetam oral solution prior enter study , levetiracetam intravenous ( LEV IV ) dose equivalent ( mg-for-mg ) oral dose ( always twice daily regimen ) within follow dose range , calculate basis age weight : - Children ≥ 1 month &lt; 6 month : 14 mg/kg/day ( i.e . 7 mg/kg twice daily ) 42 mg/kg/day ( i.e 21 mg/kg/day twice daily ) ; - Children ≥ 6 month &lt; 4 years:20 mg/kg/day ( i.e . 10 mg/kg twice daily ) 60 mg/kg/day ( i.e 30 mg/kg/day twice daily ) . The first intravenous ( IV ) infusion administer 12 hour last oral dose levetiracetam . For child take levetiracetam oral solution prior enter study , intravenous ( IV ) dose correspond age weight follow : - Children ≥ 1 month &lt; 6 month : 14 mg/kg/day ( i.e . 7 mg/kg twice daily ) . - Children ≥ 6 month &lt; 4 year : 20 mg/kg/day ( i.e . 10 mg/kg twice daily ) . However , necessary safety subject investigator deem appropriate levetiracetam intravenous ( LEV IV ) dose could modify one day . Subjects hospitalize duration levetiracetam intravenous ( LEV IV ) treatment .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Male female 1 month 4 year age , inclusive The subject suffers epilepsy ( except status epilepticus ) The subject require levetiracetam IV treatment place oral therapy short period time The subject difficult venous accessibility History status epilepticus 3 month prior Screening The subject felbamate le 18 month continuous exposure Screening . The subject present current depressive symptom , current suicidal ideation and/or behavior .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Child</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra®</keyword>
	<keyword>Infusion</keyword>
	<keyword>Intravenous</keyword>
</DOC>